GLAUKOS Corp Income Taxes Disclosure
Note 11. Income Taxes
United States and foreign (loss) income before income taxes was as follows (in thousands):
|
|
Year ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
United States |
|
$ |
(197,636 |
) |
|
$ |
(147,828 |
) |
|
$ |
(138,205 |
) |
Foreign |
|
|
4,594 |
|
|
|
2,227 |
|
|
|
4,478 |
|
Total |
|
$ |
(193,042 |
) |
|
$ |
(145,601 |
) |
|
$ |
(133,727 |
) |
The income tax (benefit) provision was as follows (in thousands):
|
|
Year ended |
|
|||||||||
|
|
December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Current: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
$ |
(64 |
) |
|
$ |
— |
|
|
$ |
(55 |
) |
State |
|
|
240 |
|
|
|
307 |
|
|
|
294 |
|
Foreign |
|
|
960 |
|
|
|
680 |
|
|
|
815 |
|
|
|
|
1,136 |
|
|
|
987 |
|
|
|
1,054 |
|
Deferred: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
|
(4,167 |
) |
|
|
4 |
|
|
|
23 |
|
State |
|
|
(2,320 |
) |
|
|
(220 |
) |
|
|
(143 |
) |
Foreign |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
(6,487 |
) |
|
|
(216 |
) |
|
|
(120 |
) |
Income tax (benefit) provision |
|
$ |
(5,351 |
) |
|
$ |
771 |
|
|
$ |
934 |
|
The reconciliations of the U.S. federal statutory tax expense to the combined effective tax (benefit) provision are as follows (in thousands):
|
|
Year ended |
|
|||||
|
|
December 31, |
|
|||||
|
|
2025 |
|
|||||
U.S. federal statutory tax rate |
|
$ |
(40,539 |
) |
|
|
21.0 |
% |
State income taxes, net of federal benefit (i) |
|
|
3,944 |
|
|
|
-2.0 |
% |
Foreign tax effects |
|
|
509 |
|
|
|
-0.3 |
% |
Effect of changes in tax laws or rates enacted in the current period |
|
|
— |
|
|
|
0.0 |
% |
Effect of cross-border tax laws |
|
|
791 |
|
|
|
-0.4 |
% |
Tax credits |
|
|
(7,377 |
) |
|
|
3.8 |
% |
Changes in valuation allowance |
|
|
51,243 |
|
|
|
-26.5 |
% |
Nontaxable or nondeductible items |
|
|
|
|
|
|
||
Permanent and other items |
|
|
717 |
|
|
|
-0.4 |
% |
Limitation on officers' compensation |
|
|
7,169 |
|
|
|
-3.7 |
% |
Stock-based compensation |
|
|
(8,583 |
) |
|
|
4.4 |
% |
Changes in unrecognized tax benefits |
|
|
(14,194 |
) |
|
|
7.4 |
% |
Other |
|
|
969 |
|
|
|
-0.5 |
% |
Income tax (benefit) provision |
|
$ |
(5,351 |
) |
|
|
2.8 |
% |
|
|
Year ended |
|
|||||
|
|
December 31, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Statutory rate of tax benefit |
|
$ |
(30,578 |
) |
|
$ |
(28,082 |
) |
State income taxes, net of federal benefit |
|
|
(5,728 |
) |
|
|
(6,436 |
) |
Permanent and other items |
|
|
2,212 |
|
|
|
5,105 |
|
Loss on extinguishment of debt |
|
|
3,657 |
|
|
|
— |
|
Limitation on officers' compensation |
|
|
6,622 |
|
|
|
— |
|
In-process research and development |
|
|
2,160 |
|
|
|
— |
|
Stock-based compensation |
|
|
(19,960 |
) |
|
|
(5,323 |
) |
Research credits |
|
|
(6,481 |
) |
|
|
(6,059 |
) |
Uncertain tax positions |
|
|
2,977 |
|
|
|
3,493 |
|
Change in tax rate |
|
|
899 |
|
|
|
1,333 |
|
State economic development credits |
|
|
— |
|
|
|
(2,370 |
) |
Valuation allowance |
|
|
44,991 |
|
|
|
39,273 |
|
Income tax provision |
|
$ |
771 |
|
|
$ |
934 |
|
The amounts of cash taxes paid by the Company are as follows (in thousands):
|
|
Year ended |
|
|
|
|
December 31, |
|
|
|
|
2025 |
|
|
Federal |
|
$ |
— |
|
State |
|
|
|
|
Illinois |
|
|
65 |
|
New York |
|
|
52 |
|
All other states |
|
|
176 |
|
Foreign |
|
|
|
|
Germany |
|
|
239 |
|
Japan |
|
|
126 |
|
France |
|
|
114 |
|
United Kingdom |
|
|
105 |
|
All other foreign |
|
|
72 |
|
Total |
|
$ |
949 |
|
Significant components of the Company’s net deferred tax assets at December 31, 2025 and December 31, 2024 are as follows (in thousands):
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Deferred tax assets: |
|
|
|
|
|
|
||
Net operating loss carryforwards |
|
$ |
121,845 |
|
|
$ |
115,938 |
|
Tax credits |
|
|
53,878 |
|
|
|
30,000 |
|
Stock-based compensation |
|
|
11,362 |
|
|
|
12,197 |
|
Reserves and accruals |
|
|
18,256 |
|
|
|
15,073 |
|
Lease liability |
|
|
25,667 |
|
|
|
25,510 |
|
Capitalized research costs |
|
|
77,479 |
|
|
|
69,372 |
|
Other, net |
|
|
726 |
|
|
|
1,481 |
|
Total deferred tax assets |
|
$ |
309,213 |
|
|
$ |
269,571 |
|
|
|
|
|
|
|
|
||
Deferred tax liabilities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
(20,370 |
) |
|
|
(51,039 |
) |
ROU lease asset |
|
|
(16,957 |
) |
|
|
(17,280 |
) |
Total deferred tax liabilities |
|
$ |
(37,327 |
) |
|
$ |
(68,319 |
) |
|
|
|
|
|
|
|
||
Valuation allowance |
|
|
(272,327 |
) |
|
|
(208,180 |
) |
Net deferred tax liability |
|
$ |
(441 |
) |
|
$ |
(6,928 |
) |
Based on the weight of available evidence, the Company has established a valuation allowance for a portion of its deferred tax assets which it expects will not be realized on a more likely than not basis. The net increase in the valuation allowance was $64.1 million in 2025.
As of December 31, 2025, the Company had approximately $546.9 million, $455.1 million and $5.8 million of NOL carryforwards for federal, state and foreign purposes, respectively. Portions of federal NOL carryforwards incurred prior to 2018 will expire annually, if unused, while $346.9 million will not expire but can only be used to offset 80 percent of federal taxable income. Additionally, portions of state and foreign NOL carryforwards will expire annually, if unused.
As of December 31, 2025, the Company had federal and state R&D credit carryforwards of approximately $56.3 million and $33.0 million, respectively. Portions of federal and $5.9 million of state credits will expire annually, if unused, while $27.1 million of state credits carry forward indefinitely. Additionally, as of December 31, 2025, the Company had California economic development credit carryforwards of $3.0 million. These economic development credits can only be used to offset California taxable income and begin to expire in 2028, if unused.
Utilization of some NOL and tax credit carryforwards will be subject to annual limitations under IRC Section 382 and Section 383 due to several ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of NOL, tax credit carryforwards, and other deferred tax assets that can be utilized to offset future taxable income and/or income tax liabilities. In general, ownership changes as defined by IRC Section 382 result from a greater than 50 percent change in the ownership of the Company’s stock among certain shareholders over a three‑year period.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 excluding interest and penalties, is as follows (in thousands):
|
|
December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Balance at beginning of the year |
|
$ |
34,594 |
|
|
$ |
32,839 |
|
|
$ |
28,968 |
|
Net addition for tax positions - prior years |
|
|
331 |
|
|
|
526 |
|
|
|
986 |
|
Net additions for tax positions - current year |
|
|
1,593 |
|
|
|
3,479 |
|
|
|
4,013 |
|
Subtractions from tax positions - prior years |
|
|
(15,669 |
) |
|
|
(2,250 |
) |
|
|
(1,128 |
) |
Subtractions from tax positions - current year |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Balance at end of the year |
|
$ |
20,849 |
|
|
$ |
34,594 |
|
|
$ |
32,839 |
|
As of December 31, 2025, approximately $2.1 million of unrecognized tax benefits would reduce the Company’s annual effective tax rate if recognized.
The Company’s policy is to recognize interest expense and penalties related to income tax matters as a component of its income tax provision. The accrued interest and penalties associated with uncertain tax positions as of December 31, 2025, December 31, 2024 and December 31, 2023 were not material.
Due to the Company’s NOL carryforwards, its U.S. income tax returns are open to examination by the Internal Revenue Service and other state taxing jurisdictions for years beginning in 2006.
There are no cumulative earnings in the Company’s foreign subsidiaries as of December 31, 2025 that would be subject to U.S. income tax or foreign withholding tax. The Company plans to indefinitely reinvest any future earnings of its foreign subsidiaries.
On July 4, 2025, House Resolution 1, commonly referred to as the One Big Beautiful Bill Act (OBBBA), was enacted into law. Key provisions of the OBBBA include the extension and modification of certain provisions of the Tax Cuts and Jobs Act of 2017, changes to bonus depreciation, adjustments to business interest expense limitations, and modifications to the treatment of research and development expenditures. The OBBBA has multiple effective dates, with certain provisions effective in 2025 and others becoming effective in 2026. In accordance with ASC 740, the effect of changes in tax rates and laws on deferred tax balances are recognized in the period when the legislation is enacted. The Company has reflected the effect of the OBBBA within the provision for income taxes and the deferred tax balances as of December 31, 2025. The OBBBA did not materially impact the Company's effective tax rate.
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid by jurisdiction. The ASU is effective for public business entities’ annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted this pronouncement on a prospective basis as of January 1, 2025.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 23, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 23, 2024 | |
| 2022 | Feb 24, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2019 | Mar 2, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Mar 15, 2017 | |
| 2015 | Mar 15, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.